XML 83 R42.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Discontinued Operations - Schedule of fail value of consideration (Details) - USD ($)
Dec. 31, 2023
Dec. 27, 2023
Dec. 11, 2023
Discontinued Operations      
Estimated fair value of 3% ANTHIM earnout $ 1,720,000    
Estimated fair value of contingent consideration receivable, related party $ 268,000    
Discontinued Operations, Disposed of by Sale | Elusys Therapeutics      
Discontinued Operations      
Upfront cash consideration   $ 500,000 $ 500,000
Estimated fair value of 3% ANTHIM earnout   1,720,000  
Contingent consideration receivable   300,000  
Estimated fair value of contingent consideration receivable, related party   268,000  
Total fair value of contingent consideration receivable, related party   1,988,000  
Total fair value of consideration received   $ 2,488,000